NCT00925782 · MORE INFO

Limitations, agreements, and source contact

PK Study of Melphalan HCL & Alkeran for Injection of MA Conditioning in MM Patients of Autologous Transplantation · Source last updated 2019-12-17

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

other Details: Institution/PI shall submit to the Sponsor for comment, any manuscript or public release of information at least 90 days prior to its submission or release. If the Sponsor requires additional time in order to protect the results of the Study by patenting or otherwise, Institution agrees to delay submitting the Publication to any third party for up to an additional 90 days after the request by Sponsor. Such request, however, must be received by Institution during the 90-day review period.
pi Sponsor Employee: false
restriction Type: OTHER
restrictive Agreement: true

point Of Contact

Complete source fields

certain Agreement

other Details: Institution/PI shall submit to the Sponsor for comment, any manuscript or public release of information at least 90 days prior to its submission or release. If the Sponsor requires additional time in order to protect the results of the Study by patenting or otherwise, Institution agrees to delay submitting the Publication to any third party for up to an additional 90 days after the request by Sponsor. Such request, however, must be received by Institution during the 90-day review period.
pi Sponsor Employee: false
restriction Type: OTHER
restrictive Agreement: true

point Of Contact

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice